David Zanoni
Momentum, growth at reasonable price, long-term horizon

WuXi PharmaTech: The Beneficiary Of Biotech Growth

With the growth of the pharmaceutical, biotech, and medical device industries looking positive for the future, this small-cap company stands to benefit as it provides necessary services and solutions to various companies in these industries. WuXi PharmaTech (NYSE:WX) is a global contract research and development services provider. WuXi's offerings are designed to help other companies reduce the time and cost for R&D. Since R&D involves high-risk and high expenses for the company's customers, improving this process is vital to their continued success which ultimately benefits everyone's health. Investors should benefit from the company's above average growth.

Company Background

The company is a result of the 2008 merger between WuXi PharmaTech, a China-based chemistry company and AppTech Laboratory Services,...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details